By reviewing the effects of phytochemicals on macrophages to treat metabolic syndrome, we found that the main signalling pathways involved are PPAR‐γ, NF‐κB, AMPK and the PI3K/AKT pathway, which also provide targets for subsequent drug development. Here, NFKB1 is linked to metabolic syndrome.